PPD Biotech

PPD is the clinical research business of Thermo Fisher Scientific and a global contract research organization serving pharmaceutical, biotechnology, medical device, academic, and government customers. The business provides end-to-end drug development, laboratory, and lifecycle management services spanning early development, Phase I-IV clinical trials, peri- and post-approval support, patient recruitment, investigator site solutions, and central laboratory services. "PPD Biotech" is not a separate operating biotech company; it most likely refers to PPD Biotech Solutions, a service offering tailored to small- and mid-sized biotech sponsors. PPD does not appear to own a proprietary therapeutic pipeline in the way a drug developer would; instead, it supports customer programs across many modalities and therapeutic areas. The business remains active under the PPD brand as a Thermo Fisher subsidiary following Thermo Fisher's acquisition of PPD in December 2021.